Eric Dobmeier, President, CEO at CHINOOK THERAPEUTICS, INC. (KDNY), bought 4,500 shares at $13.75 ($62K) on 2020-11-11, disclosed to the SEC on 2020-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.86 | 2,000 | $28K | 44.6% |
| 2 | $13.75 | 2,500 | $34K | 55.4% |
| Total | $13.80 avg | 4,500 | $62K | 100% |
| Filing → |
| KDNY | SELL | 2023-02-15 | $385K | — | Filing → |
| KDNY | SELL | 2023-02-01 | $993K | — | Filing → |
| KDNY | SELL | 2022-12-02 | $669K | — | Filing → |